Abstract
Over the past two years, the photopheresis treatment program at Yale-New Haven Hospital has treated 32 patients with cutaneous T-cell lymphoma. There were 19 erythrodermic patients who had photopheresis as their first systemic therapy. Five of these cleared 75 percent of their skin and the majority of erythrodermics achieved an improved quality of life. Those with best responses were treated earlier in the course of their disease and had more normal proportions of CD4 and CD8 subsets when compared to patients with poor responses. In addition, patients with tumor stage disease and those patients in relapse after intensive radio- and chemotherapy were treated with photopheresis. These results demonstrate that photopheresis has a role in the management of cutaneous T-cell lymphoma.
Full text
PDF









Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Braverman I. M., Yager N. B., Chen M., Cadman E. C., Hait W. N., Maynard T. Combined total body electron beam irradiation and chemotherapy for mycosis fungoides. J Am Acad Dermatol. 1987 Jan;16(1 Pt 1):45–60. doi: 10.1016/s0190-9622(87)70004-8. [DOI] [PubMed] [Google Scholar]
- Edelson R., Berger C., Gasparro F., Jegasothy B., Heald P., Wintroub B., Vonderheid E., Knobler R., Wolff K., Plewig G. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results. N Engl J Med. 1987 Feb 5;316(6):297–303. doi: 10.1056/NEJM198702053160603. [DOI] [PubMed] [Google Scholar]
- Epstein E. H., Jr, Levin D. L., Croft J. D., Jr, Lutzner M. A. Mycosis fungoides. Survival, prognostic features, response to therapy, and autopsy findings. Medicine (Baltimore) 1972 Jan;51(1):61–72. [PubMed] [Google Scholar]
- Gasparro F. P., Battista J., Song J., Edelson R. L. Rapid and sensitive analysis of 8-methoxypsoralen in plasma. J Invest Dermatol. 1988 Feb;90(2):234–236. doi: 10.1111/1523-1747.ep12462304. [DOI] [PubMed] [Google Scholar]
- Hoffman R. A., Kung P. C., Hansen W. P., Goldstein G. Simple and rapid measurement of human T lymphocytes and their subclasses in peripheral blood. Proc Natl Acad Sci U S A. 1980 Aug;77(8):4914–4917. doi: 10.1073/pnas.77.8.4914. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lamberg S. I., Green S. B., Byar D. P., Block J. B., Clendenning W. E., Douglas M. C., Epstein E. H., Jr, Fuks Z. Y., Golitz L. E., Lorincz A. L. Clinical staging for cutaneous T-cell lymphoma. Ann Intern Med. 1984 Feb;100(2):187–192. doi: 10.7326/0003-4819-100-2-187. [DOI] [PubMed] [Google Scholar]
- Sausville E. A., Eddy J. L., Makuch R. W., Fischmann A. B., Schechter G. P., Matthews M., Glatstein E., Ihde D. C., Kaye F., Veach S. R. Histopathologic staging at initial diagnosis of mycosis fungoides and the Sézary syndrome. Definition of three distinctive prognostic groups. Ann Intern Med. 1988 Sep 1;109(5):372–382. doi: 10.7326/0003-4819-109-5-372. [DOI] [PubMed] [Google Scholar]
- WRIGHT J. C., LYONS M. M., WALKER D. G., GOLOMB F. M., GUMPORT S. L., MEDREK T. J. OBSERVATIONS ON THE USE OF CANCER CHEMOTHERAPEUTIC AGENTS IN PATIENTS WITH MYCOSIS FUNGOIDES. Cancer. 1964 Aug;17:1045–1062. doi: 10.1002/1097-0142(196408)17:8<1045::aid-cncr2820170811>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]